InvestorsHub Logo
Post# of 26891
Next 10
Followers 437
Posts 42954
Boards Moderated 2
Alias Born 05/08/2006

Re: None

Friday, 11/15/2019 5:06:39 PM

Friday, November 15, 2019 5:06:39 PM

Post# of 26891
Compensated Awareness Post View Disclaimer
QualityStocksNewsBreaks – VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) Releases Q3 2019 Financial and Operating Results

VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF), an Ontario-based cannabis company recognized for its premium products and services, on Thursday released its third quarter 2019 financial and operating results. According to the update, VIVO’s net revenue increased to $6.3 million during Q3 2019, which represents a 19% increase relative to the same period last year. The increase reflects the ramp-up of the company’s licensed capacity, which is expected to generate further revenue growth in Q4 2019. “Our focus for the first half of the year was to satisfy the needs of the evolving adult-use market, provide consistent supply of quality products to medical patients, and execute our plans for cannabis 2.0,” VIVO Chief Executive Officer Barry Fishman said in the news release. “We continue to execute against our four strategic priorities and are sharply focused on accelerating our path to profitability.”

To view the full press release, visit http://ibn.fm/9HzNW

About VIVO Cannabis(TM)

VIVO, based in Napanee, Ontario, is recognized for trusted, premium cannabis products and services. It holds production and sales licenses from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology at its Canna Farms facility in Hope, B.C., and at its Vanluven facility in Napanee, Ontario. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical(TM), Fireside(TM), Canna Farms(TM) and Lumina(TM). The company is significantly expanding its production capacity and distribution channels; growing its domestic medical cannabis platform, including Harvest Medicine, its patient-centric, highly scalable network of specialty medical cannabis clinics and services; promoting production and cultivation innovation and pursuing partnership and product development opportunities; and actively focusing on growth in select international markets, including Germany and Australia. VIVO has a healthy balance sheet and is well-positioned to accelerate its growth in Canada and internationally. For more information, visit the company’s website at www.VivoCannabis.com.

NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://ibn.fm/VVCIF

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.